Studies on the mode of action of 2,2'-anhydro-1- -D-arabinofuranosylcytosine.
D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D000970:Antineoplastic Agents / Q000378:metabolism / Q000494:pharmacology*; D002247:Carbon Isotopes; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy / Q000201:enzymology; D002474:Cell-Free System; D002854:Chromatography, Paper; D003561:Cytarabine / Q000378:metabolism / Q000494:pharmacology*; D003641:Deamination; D003841:Deoxycytidine / Q000378:metabolism; D004351:Drug Resistance; D004590:Electrophoresis, Paper; D004926:Escherichia coli / Q000201:enzymology; D005260:Female; D006863:Hydrogen-Ion Concentration; D006868:Hydrolysis; D007939:Leukemia L1210 / Q000188:drug therapy / Q000201:enzymology; D051379:Mice; D008815:Mice, Inbred Strains; D010085:Oxidative Phosphorylation
D000970:Antineoplastic Agents; D002247:Carbon Isotopes; D003561:Cytarabine; D003841:Deoxycytidine; D000255:Adenosine Triphosphate